Galanin receptors as a potential target for neurological disease.

scientific article published on 28 July 2015

Galanin receptors as a potential target for neurological disease. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1517/14728222.2015.1072513
P698PubMed publication ID26220265

P50authorKaido KurrikoffQ44567523
Ülo LangelQ47087785
P2093author name stringKrista Freimann
P2860cites workIntraventricular galanin modulates a 5-HT1A receptor-mediated behavioural response in the rat.Q48388908
Galanin-5-hydroxytryptamine interactions: electrophysiological, immunohistochemical and in situ hybridization studies on rat dorsal raphe neurons with a note on galanin R1 and R2 receptorsQ48403369
Restricted distribution of galanin receptor 3 (GalR3) mRNA in the adult rat central nervous systemQ48457696
Characterization and localization of galanin receptors in human entorhinal cortexQ48485114
Galanin receptor over-expression within the amygdala in early Alzheimer's disease: an in vitro autoradiographic analysisQ48504105
Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalitiesQ48864164
Role of galanin receptor 1 and galanin receptor 2 activation in synaptic plasticity associated with 3',5'-cyclic AMP response element-binding protein phosphorylation in the dentate gyrus: studies with a galanin receptor 2 agonist and galanin receptoQ48891603
Distribution of galaninergic immunoreactivity in the brain of the mouseQ48893571
Reduction of choline acetyltransferase activity in primary visual cortex in mild to moderate Alzheimer's diseaseQ48967823
Intraventricular galanin produces a time-dependent modulation of 5-HT1A receptors in the dorsal raphe of the rat.Q49012883
Localization of preprogalanin messenger RNA in rat brain: identification of transcripts in a subpopulation of cerebellar Purkinje cellsQ49123493
Effect of intrathecal galanin and its putative antagonist M35 on pain behavior in a neuropathic pain modelQ49149270
Constitutive and ligand-induced internalization of EGFP-tagged galanin R2 and Rl receptors in PC12 cellsQ50766587
Galanin neurons in the intermediate nucleus (InM) of the human hypothalamus in relation to sex, age, and gender identityQ51458133
Galanin impairs acquisition but not retrieval of spatial memory in rats studied in the Morris swim mazeQ52123291
Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson's disease with and without dementia and depressionQ53187673
Molecular characterization and expression of cloned human galanin receptors GALR2 and GALR3Q22008499
Molecular cloning of a functional human galanin receptorQ24306226
Cloned human and rat galanin GALR3 receptors. Pharmacology and activation of G-protein inwardly rectifying K+ channelsQ24309179
Molecular characterization, pharmacological properties and chromosomal localization of the human GALR2 galanin receptorQ24319129
Galanin pathogenic mutations in temporal lobe epilepsyQ24319705
Anticonvulsant activity of a nonpeptide galanin receptor agonistQ24531395
Patterns of seizures, hippocampal injury and neurogenesis in three models of status epilepticus in galanin receptor type 1 (GalR1) knockout miceQ24537325
Anxiolytic- and antidepressant-like profiles of the galanin-3 receptor (Gal3) antagonists SNAP 37889 and SNAP 398299.Q24537645
Synthesis of galmic: a nonpeptide galanin receptor agonistQ24559130
Galmic, a nonpeptide galanin receptor agonist, affects behaviors in seizure, pain, and forced-swim testsQ24564195
Galanin in Alzheimer's disease: neuroinhibitory or neuroprotective?Q24601893
Phenotypic analysis of GalR2 knockout mice in anxiety- and depression-related behavioral testsQ24630830
Genome-wide atlas of gene expression in the adult mouse brainQ26253934
A novel, systemically active, selective galanin receptor type-3 ligand exhibits antidepressant-like activity in preclinical testsQ28252871
Critical role for GALR1 galanin receptor in galanin regulation of neuroendocrine function and seizure activityQ48269162
Galanin: a significant role in depression?Q48294893
Galanin inhibits performance on rodent memory tasksQ48294914
Galanin modulates 5-hydroxytryptamine functions. Focus on galanin and galanin fragment/5-hydroxytryptamine1A receptor interactions in the brainQ48294936
Galanin reduces release of endogeneous excitatory amino acids in the rat hippocampusQ48320065
Galanin receptor antagonists M40 and C7 block galanin-induced feedingQ48346724
Structural organization of the mouse and human GALR1 galanin receptor genes (Galnr and GALNR) and chromosomal localization of the mouse geneQ28254468
Differential role of galanin receptors in the regulation of depression-like behavior and monoamine/stress-related genes at the cell body levelQ28263350
Galanin and its receptors in neurological disordersQ28264297
Galanin attenuates beta-amyloid (Abeta) toxicity in rat cholinergic basal forebrain neuronsQ28278813
Galanin and epilepsyQ28281285
Genomic organization and localization of the gene encoding human preprogalaninQ28285645
Cloning and characterization of the human galanin GALR2 receptorQ28293104
Design, synthesis, and characterization of high-affinity, systemically-active galanin analogues with potent anticonvulsant activitiesQ28302683
The brain galanin receptors: targets for novel antidepressant drugsQ28303033
Novel galanin receptor subtype specific ligands in feeding regulationQ28305689
The galanin peptide family: receptor pharmacology, pleiotropic biological actions, and implications in health and diseaseQ28307983
Expression Cloning of a Rat Hypothalamic Galanin Receptor Coupled to Phosphoinositide TurnoverQ28572322
Visualization of a functionally enhanced GFP-tagged galanin R2 receptor in PC12 cells: constitutive and ligand-induced internalizationQ28575154
Differential Intracellular Signaling of the GalR1 and GalR2 Galanin Receptor SubtypesQ28582628
Binding of Chimeric Peptides M617 and M871 to Galanin Receptor Type 3 Reveals Characteristics of Galanin Receptor–Ligand InteractionQ29040426
Phenotypic analysis of mice deficient in the type 2 galanin receptor (GALR2).Q30475920
Deficits in trace cued fear conditioning in galanin-treated rats and galanin-overexpressing transgenic miceQ30532216
Effects of centrally administered galanin (1-16) on galanin expression in the rat hypothalamusQ30968681
Galanin hyperinnervation upregulates choline acetyltransferase expression in cholinergic basal forebrain neurons in Alzheimer's disease.Q33678393
Colocalization of galanin and luteinizing hormone-releasing hormone in a subset of preoptic hypothalamic neurons: anatomical and functional correlatesQ33750501
The role of galanin in feeding behaviorQ33829084
Galanin fiber hyperinnervation preserves neuroprotective gene expression in cholinergic basal forebrain neurons in Alzheimer's disease.Q33908982
Receptor subtype-specific pronociceptive and analgesic actions of galanin in the spinal cord: selective actions via GalR1 and GalR2 receptorsQ33934812
GalR2-positive allosteric modulator exhibits anticonvulsant effects in animal modelsQ34093567
Cloning and characterization of a novel G-protein-coupled receptor with homology to galanin receptorsQ34316713
Galanin inhibits acetylcholine release in the ventral hippocampus of the rat: histochemical, autoradiographic, in vivo, and in vitro studiesQ34356002
Galanin/GALP and galanin receptors: role in central control of feeding, body weight/obesity and reproduction?Q34635512
Construction of a porcine adrenal medullary cDNA library and nucleotide sequence analysis of two clones encoding a galanin precursorQ35054541
Differential activity by polymorphic variants of a remote enhancer that supports galanin expression in the hypothalamus and amygdala: implications for obesity, depression and alcoholismQ35222822
Galanin and galanin receptors in epilepsyQ35965246
Galanin receptor ligandsQ36156070
Galanin and spinal nociceptive mechanisms: recent results from transgenic and knock-out modelsQ36156098
Galanin receptors and ligandsQ36451712
Postendocytotic traffic of the galanin R1 receptor: a lysosomal signal motif on the cytoplasmic terminusQ36535543
Galanin impairs cognitive abilities in rodents: relevance to Alzheimer's diseaseQ37171921
A role for galanin in human and experimental inflammatory demyelinationQ37320724
Galanin acts as a neuroprotective factor to the hippocampusQ37416301
Impairment of memory consolidation by galanin correlates with in vivo inhibition of both LTP and CREB phosphorylationQ37436783
Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer diseaseQ37546301
Galanin stimulates neurite outgrowth from sensory neurons by inhibition of Cdc42 and Rho GTPases and activation of cofilinQ37604336
M-15: high-affinity chimeric peptide that blocks the neuronal actions of galanin in the hippocampus, locus coeruleus, and spinal cordQ37638977
Physiology, signaling, and pharmacology of galanin peptides and receptors: three decades of emerging diversityQ38271920
cDNA sequence, ligand biding, and regulation of galanin/GMAP in mouse brainQ38289093
Distribution of galanin messenger RNA-expressing cells in murine brain and their regulation by leptin in regions of the hypothalamusQ38303344
Galanin-R1 and -R2 receptor mRNA expression during the development of rat brain suggests differential subtype involvement in synaptic transmission and plasticityQ38308638
Galanin type 2 receptors regulate neuronal survival, susceptibility to seizures and seizure-induced neurogenesis in the dentate gyrusQ38339673
Galanin (2-11) binds to GalR3 in transfected cell lines: limitations for pharmacological definition of receptor subtypesQ40412251
Regulation of anterior pituitary galanin gene expression by thyroid hormone.Q41071863
The revised monoamine theory of depression: a modulatory role for monoamines, based on new findings from monoamine depletion experiments in humansQ41148169
Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia.Q41255070
Characterization of the 5'-flanking region of the human preprogalanin geneQ41357210
On the existence and function of galanin receptor heteromers in the central nervous systemQ41889343
Galanin fiber hypertrophy within the cholinergic nucleus basalis during the progression of Alzheimer's disease.Q42489299
Distribution of galanin-like immunoreactivity in the human brainQ42490902
Activation of the galanin receptor 2 (GalR2) protects the hippocampus from neuronal damageQ42507592
Galanin/GMAP- and NPY-like immunoreactivities in locus coeruleus and noradrenergic nerve terminals in the hippocampal formation and cortex with notes on the galanin-R1 and -R2 receptorsQ42544280
Behavioural characterisation of young adult transgenic mice overexpressing galanin under the PDGF-B promoterQ42642053
Galanin: stimulation of feeding induced by medial hypothalamic injection of this novel peptideQ43437739
2,3-Dihydro-dithiin and -dithiepine-1,1,4,4-tetroxides: small molecule non-peptide antagonists of the human galanin hGAL-1 receptorQ43505099
Galanin immunoreactivity is increased in the nucleus basalis of Meynert in Alzheimer's diseaseQ44045750
Immunohistochemical mapping of galanin-like neurons in the rat central nervous systemQ44097639
Exogenous galanin attenuates spatial memory impairment and decreases hippocampal β-amyloid levels in rat model of Alzheimer's diseaseQ44260000
Evidence for a role of the neuropeptide galanin in spatial learningQ44332862
Anticonvulsive effects of galanin administered into the central nervous system upon the picrotoxin-kindled seizure syndrome in ratsQ44399336
Altered hippocampal expression of neuropeptides in seizure-prone GALR1 knockout miceQ44530091
Microarray analysis of postictal transcriptional regulation of neuropeptidesQ46412841
Homodimerization and internalization of galanin type 1 receptor in living CHO cellsQ46768490
Galanin receptor-1 knockout mice exhibit spontaneous epilepsy, abnormal EEGs and altered inhibition in the hippocampusQ46769076
Isolation and cDNA cloning of a novel galanin-like peptide (GALP) from porcine hypothalamusQ47900449
Evidence for Hydrophobic Interaction between Galanin and the GalR1 Galanin Receptor and GalR1-Mediated Ligand Internalization: Fluorescent Probing with a Fluorescein−GalaninQ47900849
NGF and LIF both regulate galanin gene expression in primary DRG culturesQ47959103
Cloning and expressional characterization of a novel galanin receptor. Identification of different pharmacophores within galanin for the three galanin receptor subtypesQ48040979
Molecular cloning and characterisation of the mouse preprogalanin geneQ48056889
Galanin selectively modulates 5-hydroxytryptamine 1A receptors in the rat ventral limbic cortexQ48112060
Intracerebroventricular administration of galanin or galanin receptor subtype 1 agonist M617 induces c-Fos activation in central amygdala and dorsomedial hypothalamus.Q48253532
P433issue12
P407language of work or nameEnglishQ1860
P304page(s)1665-1676
P577publication date2015-07-28
P13046publication type of scholarly workreview articleQ7318358
P1433published inExpert Opinion on Therapeutic TargetsQ5421214
P1476titleGalanin receptors as a potential target for neurological disease
P478volume19

Reverse relations

cites work (P2860)
Q41139465An analysis of possible off target effects following CAS9/CRISPR targeted deletions of neuropeptide gene enhancers from the mouse genome
Q38935590Challenges for the in vivo quantification of brain neuropeptides using microdialysis sampling and LC-MS.
Q38766134Dataset on Galanin Receptor 3 mutants that improve recombinant receptor expression and stability in an agonist and antagonist bound form
Q41120997Epigenetic inactivation of galanin and GALR1/2 is associated with early recurrence in head and neck cancer
Q88213463Neuronal hypothalamic regulation of body metabolism and bone density is galanin dependent
Q60938770Neuropeptide and Small Transmitter Coexistence: Fundamental Studies and Relevance to Mental Illness
Q47961085Site-specific methylation patterns of the GAL and GALR1/2 genes in head and neck cancer: Potential utility as biomarkers for prognosis
Q47597808Trends in GPCR drug discovery: new agents, targets and indications.
Q37681012Zinc in the Monoaminergic Theory of Depression: Its Relationship to Neural Plasticity.